Both acute and prolonged administration of EPO reduce cerebral and systemic vascular conductance in humans

FASEB Journal

Volumn 26, Issue 3, 2012, Pages 1343-1348

  Rasmussen, Peter ^a,c   Kim, Yu Sok ^d   Krogh Madsen, Rikke ^a   Lundby, Carsten ^a,c   Olsen, Niels V ^a,b   Secher, Niels H ^a   Van Lieshout, Johannes J ^d,e  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Exercise; Hypoxia; Neuroprotective agents

Indexed keywords

ERYTHROPOIETIN;

ADULT; ARTERIAL PRESSURE; ARTICLE; AUTOREGULATION; BLOOD FLOW VELOCITY; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CONDUCTANCE; CYCLING; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; HYPOXIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ERYTHROPOIETIN; EXERCISE; HEMATOCRIT; HOMEOSTASIS; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; OXYGEN; OXYGEN CONSUMPTION; TIME FACTORS; VASOCONSTRICTION; YOUNG ADULT;

EID: 84863244346     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-193508     Document Type: Article

References (27)

1. Jelkmann, W. (2011) Regulation of erythropoietin production. J. Physiol. 589, 1251-1258
2. Fisher, J. W. (2003) Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood) 228, 1-14
3. Santhanam, A. V., Smith, L. A., Nath, K. A., and Katusic, Z. S. (2006) In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 291, H781-H786 (Pubitemid 44175085)
4. Bernaudin, M., Bellail, A., Marti, H. H., Yvon, A., Vivien, D., Duchatelle, I., Mackenzie, E. T., and Petit, E. (2000) Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 30, 271-278 (Pubitemid 30259666)
5. Siren, A. L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., Mennini, T., Heumann, R., Cerami, A., Ehrenreich, H., and Ghezzi, P. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98, 4044-4049 (Pubitemid 32249895)
6. Tseng, M. Y., Hutchinson, P. J., Richards, H. K., Czosnyka, M., Pickard, J. D., Erber, W. N., Brown, S., and Kirkpatrick, P. J. (2009) Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial. Clinical article. J. Neurosurg. 111, 171-180
7. Krapf, R., and Hulter, H. N. (2009) Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin. J. Am. Soc. Nephrol. 4, 470-480
8. Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P. D., Bohn, M., Becker, H., Wegrzyn, M., Jahnig, P., Herrmann, M., Knauth, M., Bahr, M., Heide, W., Wagner, A., Schwab, S., Reichmann, H., Schwendemann, G., Dengler, R., Kastrup, A., and Bartels, C. (2009) Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40, e647-656
9. Frietsch, T., Maurer, M. H., Vogel, J., Gassmann, M., Kuschinsky, W., and Waschke, K. F. (2007) Reduced cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin overexpressing transgenic mice with excessive erythrocytosis. J. Cereb. Blood Flow Metab. 27, 469-476
10. McMahon, F. G., Vargas, R., Ryan, M., Jain, A. K., Abels, R. I., Perry, B., and Smith, I. L. (1990) Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood 76, 1718-1722
11. Panerai, R. B., Dawson, S. L., and Potter, J. F. (1999) Linear and nonlinear analysis of human dynamic cerebral autoregulation. Am. J. Physiol. 277, H1089-1099 (Pubitemid 29459625)
12. Lundby, C., Thomsen, J. J., Boushel, R., Koskolou, M., Warberg, J., Calbet, J. A., and Robach, P. (2007) Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume. J. Physiol. 578, 309-314 (Pubitemid 44971127)
13. Ainslie, P. N., Cotter, J. D., George, K. P., Lucas, S., Murrell, C., Shave, R., Thomas, K. N., Williams, M. J., and Atkinson, G. (2008) Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human ageing. J. Physiol. 586, 4005-4010
14. Lundby, C., Robach, P., Boushel, R., Thomsen, J. J., Rasmussen, P., Koskolou, M., and Calbet, J. A. (2008) Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport? J. Appl. Physiol. 105, 581-587
15. Rasmussen, P., Foged, E. M., Krogh-Madsen, R., Nielsen, J., Nielsen, T. R., Olsen, N. V., Petersen, N. C., Sorensen, T. A., Secher, N. H., and Lundby, C. (2010) Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men. J. Appl. Physiol. 109, 476-483
16. Jellema, W. T., Imholz, B. P., van Goudoever, J., Wesseling, K. H., and van Lieshout, J. J. (1996) Finger arterial versus intrabrachial pressure and continuous cardiac output during head-up tilt testing in healthy subjects. Clin. Sci. (London) 91, 193-200 (Pubitemid 26258032)
17. Diehl, R. R., Linden, D., Lucke, D., and Berlit, P. (1995) Phase relationship between cerebral blood flow velocity and blood pressure. A clinical test of autoregulation. Stroke 26, 1801-1804
18. Immink, R. V., van Montfrans, G. A., Stam, J., Karemaker, J. M., Diamant, M., and van Lieshout, J. J. (2005) Dynamic cerebral autoregulation in acute lacunar and middle cerebral artery territory ischemic stroke. Stroke 36, 2595-2600
19. Immink, R. V., van den Born, B. J., van Montfrans, G. A., Koopmans, R. P., Karemaker, J. M., and van Lieshout, J. J. (2004) Impaired cerebral autoregulation in patients with malignant hypertension. Circulation 110, 2241-2245 (Pubitemid 39372508)
20. Lundby, C., and Olsen, N. V. (2011) Effects of recombinant human erythropoietin in normal humans. J. Physiol. 589, 1265-1271
21. Cirillo, M., Laurenzi, M., Trevisan, M., and Stamler, J. (1992) Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension 20, 319-326
22. Van Lieshout, J. J., Wieling, W., Karemaker, J. M., and Secher, N. H. (2003) Syncope, cerebral perfusion, and oxygenation. J. Appl. Physiol. 94, 833-848 (Pubitemid 36231994)
23. Pott, F., Ray, C. A., Olesen, H. L., Ide, K., and Secher, N. H. (1997) Middle cerebral artery blood velocity, arterial diameter and muscle sympathetic nerve activity during post-exercise muscle ischaemia. Acta Physiol. Scand. 160, 43-47 (Pubitemid 27223426)
24. Wilson, M. H., Edsell, M. E., Davagnanam, I., Hirani, S. P., Martin, D. S., Levett, D. Z., Thornton, J. S., Golay, X., Strycharczuk, L., Newman, S. P., Montgomery, H. E., Grocott, M. P., and Imray, C. H. (2011) Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia-an ultrasound and MRI study J. Cereb. Blood Flow Metab. 31, 2019-2029
25. Bode-Boger, S. M., Boger, R. H., Kuhn, M., Radermacher, J., and Frolich, J. C. (1992) Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietin. J. Cardiovasc. Pharmacol. 20(Suppl. 12), S25-S28 (Pubitemid 23014100)
26. Carlini, R. G., Dusso, A. S., Obialo, C. I., Alvarez, U. M., and Rothstein, M. (1993) Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int. 43, 1010-1014 (Pubitemid 23137084)
27. Grasso, G., Sfacteria, A., Meli, F., Passalacqua, M., Fodale, V., Buemi, M., Giambartino, F., Iacopino, D. G., and Tomasello, F. (2007) The role of erythropoietin in neuroprotection: therapeutic perspectives. Drug News Perspect. 20, 315-320 (Pubitemid 47345223)